United States Bioinformatics Market is anticipated to grow with growing investments in the healthcare industry, in the forecast period, 2023-2027F.
According to TechSci Research report on, “United States Bioinformatics Market - By Region, Competition Forecast & Opportunities, 2027”, United States bioinformatics market might register an impressive CAGR during the forecast period, 2023-2027, to establish growth due to technological advancement in the biotechnology sector of the healthcare industry. Biotechnology & genetics holds a vast arena for the advancement and evolution that can help in the advancement of medicine and therapeutic processes. Identification of the unknown species, identifying the microorganisms, the protein translations, DNA & RNA analysis, genomic studies, pharmacogenomics, are various sectors that revolves on the advancements of bioinformatics.
Bioinformatics in simple terms is defined as the applications of computing systems, mathematics, physics and biology altogether. The field includes applications of computer programs that enable efficient access to, management, and use of, various types of information and development of the new algorithms and statistical measures that allows the use of big data technologies. Gene prediction, protein analysis, protein structure predictions, etc. are feasible due to bioinformatics. The bioinformatics applies into pattern recognition, data mining, machine learning algorithms, and visualization. Further researches include gene expression and protein–protein interactions, genome-wide association studies, the modeling of evolution and cell division/mitosis.
Demands for advanced medicine, genomic drugs, precision medicine aids to the growth of the United States bioinformatics market in the upcoming five years. Increasing instances of infectious diseases, new infectious disease spreads, growing instances of rare diseases, and rapid evolution in the microorganisms that cause severe diseases further supports the growth of the United States bioinformatics market in the next five years. The government is actively investing in the research and development of the technologies and data storage further aids the growth of the United States bioinformatics market in the future five years.
Browse over XX market data Figures spread through 70 Pages and an in-depth TOC on "United States Bioinformatics Market"
The United States bioinformatics market is segmented by product & services, type, application, end user, competitional landscape, and regional distribution.
Based on product & services, the market is further segmented into bioinformatics tools, bioinformatics platforms, and bioinformatics services. Bioinformatics platforms are anticipated to hold the largest revenue shares of the market and dominate the market segment in the upcoming five years on the grounds of rowing demand for data analytics and data engineering. The growing demand for various sequencing techniques like nanopore sequencing, DNA & RNA sequencing, protein sequencing, Next-generation sequencing, etc. further supports the growth of the sub-segment along with the growth of the United States bioinformatics market in the next five years.
By type, the market is fragmented into genomics & proteomics, simulation studies & molecular modelling, genetic engineering, and others. Simulation studies & molecular modelling is anticipated to hold the largest revenue shares of the market and dominate the segment in the upcoming five years on grounds of growing demands from the biopharmaceuticals companies and increasing demands for the drug development and discovery. Higher investments, growing research and development of the therapeutics and pharmaceuticals further aids the growth of the United States bioinformatics market in the future five years.
Based on application, the market is bifurcated into metagenomics, drug discovery, precision medicine, and others. Precision medicine is anticipated to hold the largest revenue shares of the market and dominate the market segment in the future five years due to growing demands for the advanced pharmaceuticals with the specific genetic medicines and similar pharmacological products. By end user, the market is differentiated between institutional research and industrial research.
A partial list of major market players of the United States bioinformatics market includes:
- Illumina, Inc.
- Thermo Fischer Scientific, Inc.
- Agilent Technologies, Inc.
- PerkinElmer Inc.
- QIAGEN Inc.
- DataTrack International, Inc.
- Biovia-Dassault Systemes
- Waters Corporation
- SOPHiA GENETICS
Download Free Sample Report @
Customers can also request for 10% free customization on this report.
“Institutional research is the key element that is driving the growth of the large market shares along with the applications in medical biotechnology. Advancements in the biotechnology procedures include nanopore sequencing technology, protein sequencing, Next-generation sequencing, DNA & RNA sequencing, etc. that are consistently carried out as institutional research. The researches carried out are usually to discover potential cause of infectious disease, drug discovery, categorization and analysis of the diseases and disease causing microbes. Industrial research is often carried out for the drug development procedures. To find drug delivery system, and advances in other pharmaceutical products. The research and development segment in the healthcare industry in the United States is anticipated to grow exponentially with the growing investment and surging demands for the technological advancement in genome projects. New market players may invest in the research sector and form merger & acquisitions for the future market growth,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“United States Bioinformatics Market By Product & Services (Bioinformatics Tools, Bioinformatics Platforms, Bioinformatics Services), By Type (Genomics & Proteomics, Simulation Studies & Molecular Modelling, Genetic Engineering, Others), By Application (Metagenomics, Drug Discovery, Precision Medicine, Others), By End User (Institutional Research v/s Industrial Research), By Region, Competition Forecast & Opportunities, 2027” has evaluated the future growth potential of United States bioinformatics market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in United States bioinformatics market.